Screening persons newly diagnosed with HIV/AIDS for risk of intimate partner violence: early progress in changing practice

Journal of Public Health Management and Practice : JPHMP
Susan J KleinGuthrie S Birkhead

Abstract

Interventions to prevent intimate partner violence (IPV), including among those at risk for or living with HIV/AIDS, are needed. In 2001, screening persons who test positive for HIV for risk of IPV was required in New York State, launching the first large-scale program to screen for IPV risk in conjunction with HIV counseling and testing (HCT). Written surveys of counselors, physicians, and agency supervisors explored attitudes, practices, knowledge, and training needs surrounding screening for risk of IPV during HCT. Most HCT providers were aware of screening requirements, but practice varied. Counselors were more likely to screen than were physicians and asked more screening questions. Despite guidelines, screening was generally not standardized and sporadic. IPV screening in conjunction with HCT is possible. Building capacity and commitment of local HCT providers through provision of training and by fostering partnerships with public health partner services staff can help overcome identified barriers to preventing IPV in a high-risk population.

References

Jun 10, 1992·JAMA : the Journal of the American Medical Association·C E Koop, G B Lundberg
Oct 14, 1993·The New England Journal of Medicine·R L North, K H Rothenberg
Nov 1, 1995·Health Care for Women International·K K EbyW S Davidson
Apr 1, 1997·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·M E McGrathL St Angelo
Nov 20, 1997·AIDS·K A Fenton, T A Peterman
Aug 12, 1999·JAMA : the Journal of the American Medical Association·M A RodriguezK Grumbach
Sep 16, 1999·The New England Journal of Medicine·S A Eisenstat, L Bancroft
Feb 10, 2000·American Journal of Public Health·S ZierlerS A Bozzette
Feb 26, 2000·The New England Journal of Medicine·W I Hofman
Feb 7, 2001·American Journal of Public Health·M CohenS Melnick
May 16, 2000·Archives of Family Medicine·A L CokerR E McKeown
Oct 4, 2000·JAMA : the Journal of the American Medical Association·J P Koplan, D W Fleming
Oct 13, 2000·American Journal of Public Health·S J KleinG Wright
Nov 7, 2000·American Journal of Preventive Medicine·J WaalenL E Saltzman
Dec 15, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·J E MaherM L Kamb
Oct 30, 2001·Journal of Public Health Management and Practice : JPHMP·S J Klein
Mar 29, 2002·American Journal of Public Health·Gail E WyattNicole Presley
Jul 18, 2002·American Journal of Preventive Medicine·Barbara GerbertNona Caspers
Aug 10, 2002·BMJ : British Medical Journal·Jean RamsayGene Feder
Oct 31, 2002·American Journal of Preventive Medicine·Ann L CokerPaige H Smith
Feb 7, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Matthew R GoldenH Hunter Handsfield
Feb 13, 2003·JAMA : the Journal of the American Medical Association·C Nadine Wathen, Harriet L MacMillan
Mar 5, 2004·Annals of Internal Medicine·UNKNOWN U. S. Preventive Services Task Force
Mar 5, 2004·Annals of Internal Medicine·Heidi D NelsonUNKNOWN U. S. Preventive Services Task Force
Dec 2, 2004·Social Science & Medicine·Bronwen Lichtenstein
Feb 4, 2005·AIDS and Behavior·Gail E WyattTamra B Loeb
May 11, 2005·Archives of Internal Medicine·Megan R GerberLaura A McCloskey
Mar 1, 2006·Sexually Transmitted Diseases·Warren F PassinUNKNOWN HIV/AIDS Prevention Research Synthesis Project Team
May 18, 2006·American Journal of Preventive Medicine·Ann L Coker

❮ Previous
Next ❯

Citations

Nov 13, 2013·The Journal of the Association of Nurses in AIDS Care : JANAC·Deborah Y PhillipsNgozi Okoro
Sep 28, 2013·The Journal of the Association of Nurses in AIDS Care : JANAC·Myriam GlémaudMichael A Kolber
Oct 9, 2013·Public Health Nursing·Kayleigh M ProwseMelissa A Sutherland
Jan 15, 2015·AIDS Patient Care and STDs·Sadaf E RaissiM John Gill
Jun 11, 2016·AIDS Patient Care and STDs·Amy BraksmajerJames McMahon
Jul 23, 2011·Violence and Victims·Anthony S DiStefano, Randolph D Hubach
Aug 19, 2008·Journal of Public Health Management and Practice : JPHMP·M Nelson KimberlyM Goldbaum Gary
Dec 30, 2015·Clinical Pediatrics·Nikhil PaiJonathon L Maguire
Apr 5, 2021·American Journal of Preventive Medicine·Ansley B Lemons-LynR Luke Shouse

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.